Substituted bicyclic compounds as bromodomain inhibitors
US9999616B2 · kind B2 · utility
0Cited by
29References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 20, 2017 |
| Grant date | Jun 19, 2018 |
| Priority date | — |
| Expiry date | Apr 20, 2037 |
Classification
- Technology area (CPC —)General
Abstract
The invention relates to substituted bicyclic compounds, which are useful for inhibition of BET protein function by binding to bromodomains, pharmaceutical compositions comprising these compounds, and use of the compounds and compositions in therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.